公司資料
Basilea Pharmaceutica 股價、新聞與催化劑
- 股票代碼:
- BSLN
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Switzerland and trades in the U
股價為何變動
Current closing-price context is not available for BSLN.
公司概覽
業務概覽
Basilea Pharmaceutica is a specialty pharmaceutical company focused on infectious disease and oncology. Its business combines marketed products and development activity in niche therapeutic areas.
所在地與產業分類
Basilea is headquartered in Switzerland and trades in the U.S. market. It sits in specialty pharma and anti-infectives.
商業模式特徵
The company depends on product revenue, pipeline progress, and strategic commercialization in focused markets. Investors watch earnings, product launches, and development milestones.
生技產業定位
Basilea occupies a specialty-pharma niche with catalyst sensitivity around infectious disease and oncology assets. It is more commercial than early-stage biotech but still tied to pipeline progress.
未來催化劑
- Basilea’s catalysts are antifungal and antibacterial product execution, plus any licensing or commercialization update that strengthens the portfolio. The company moves on steady recurring pharmaceutical demand.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。